Shanghai Shen Lian Biomedical Corporation News

Shenlian Biotech (688098): Net profit returned to the mother in 23Q1 was -34% compared to 34%. Diversified emerging vaccine business layout is expected to open up an increase in performance

國信證券May 12, 2023 00:00

Ruicai look at the market-application for new shares: Xiangxin Technology (002965), Shenlian Biology (688098), Haier Biology (688139), Hausai (002963): this plate reported seven companies' net profit doubled in three quarters! how do you have a good chance

恆泰證券Oct 15, 2019 00:00